ReviewClinical drug investigation2020

Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety.

Young Ran Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.